[A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders].
After a preliminary encouraging trial of mepiprazol (EMD 16.923) on 8 patients, a double-blind cross-over study of mepiprazol and diazepam was performed in order to compare their effect in the treatment of neurotic disorders, particularly on various forms of anxiety.
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D012647:Self-Assessment; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010879:Piperazines; D011720:Pyrazoles; D014149:Tranquilizing Agents; D003975:Diazepam
Etude contrôlée selon la méthode du double insu cross over de l'efficacit-57e compar-57ee du mepiprazol (EMD 16.923) et du diazepam dans le traitement des troubles n-57evrotiques